Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 96

1.

Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors.

Terbuch A, Posch F, Bauernhofer T, Pichler M, Peinsith H, Szkandera J, Riedl J, Hutterer GC, Pummer K, Partl R, Kapp KS, Stöger H, Stotz M, Gerger A.

Anticancer Res. 2019 Oct;39(10):5589-5596. doi: 10.21873/anticanres.13753.

PMID:
31570454
2.

Comparison of early postoperative pain after partial tumour nephrectomy by flank, transabdominal or laparoscopic access.

Hager B, Herzog SA, Hager B, Sandner-Kiesling A, Zigeuner R, Pummer K.

Br J Pain. 2019 Aug;13(3):177-184. doi: 10.1177/2049463718808542. Epub 2018 Oct 23.

PMID:
31308942
3.

Prognostic value of B7-H1, B7-H3 and the stage, size, grade and necrosis (SSIGN) score in metastatic clear cell renal cell carcinoma.

Mischinger J, Fröhlich E, Mannweiler S, Meindl C, Absenger-Novak M, Hutterer GC, Seles M, Augustin H, Chromecki TF, Jesche-Chromecki J, Pummer K, Zigeuner R.

Cent European J Urol. 2019;72(1):23-31. doi: 10.5173/ceju.2018.1858. Epub 2019 Mar 14.

4.

MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.

Terbuch A, Adiprasito JB, Stiegelbauer V, Seles M, Klec C, Pichler GP, Resel M, Posch F, Lembeck AL, Stöger H, Szkandera J, Pummer K, Bauernhofer T, Hutterer GC, Gerger A, Stotz M, Pichler M.

Int J Mol Sci. 2018 Oct 12;19(10). pii: E3130. doi: 10.3390/ijms19103130.

5.

Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.

Terbuch A, Posch F, Partl R, Zurl B, Bauernhofer T, Pichler M, Szkandera J, Hutterer GC, Pummer K, Kapp KS, Stöger H, Gerger A, Stotz M.

Cancer Med. 2018 Feb;7(2):508-514. doi: 10.1002/cam4.1317. Epub 2018 Jan 19.

6.

Blood Platelet Volume Represents a Novel Prognostic Factor in Patients with Nonmetastatic Renal Cell Carcinoma and Improves the Predictive Ability of Established Prognostic Scores.

Seles M, Posch F, Pichler GP, Gary T, Pummer K, Zigeuner R, Hutterer GC, Pichler M.

J Urol. 2017 Dec;198(6):1247-1252. doi: 10.1016/j.juro.2017.07.036. Epub 2017 Jul 14.

PMID:
28716649
7.

Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.

Bezan A, Posch F, Ploner F, Bauernhofer T, Pichler M, Szkandera J, Hutterer GC, Pummer K, Gary T, Samonigg H, Beyer J, Winder T, Hermanns T, Fankhauser CD, Gerger A, Stotz M.

PLoS One. 2017 Apr 21;12(4):e0176283. doi: 10.1371/journal.pone.0176283. eCollection 2017.

8.

The Long-Term Effect of Radical Prostatectomy on Erectile Function, Urinary Continence, and Lower Urinary Tract Symptoms: A Comparison to Age-Matched Healthy Controls.

Mohamad Al-Ali B, Ponholzer A, Augustin H, Madersbacher S, Pummer K.

Biomed Res Int. 2017;2017:9615080. doi: 10.1155/2017/9615080. Epub 2017 Feb 5.

9.

Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.

Smolle MA, Bauernhofer T, Pummer K, Calin GA, Pichler M.

Int J Mol Sci. 2017 Feb 22;18(2). pii: E473. doi: 10.3390/ijms18020473. Review.

10.

Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.

Dalpiaz O, Luef T, Seles M, Stotz M, Stojakovic T, Pummer K, Zigeuner R, Hutterer GC, Pichler M.

Br J Cancer. 2017 Jan 3;116(1):85-90. doi: 10.1038/bjc.2016.393. Epub 2016 Dec 1.

11.

Validation of the Preoperative Platelet-to-Lymphocyte Ratio as a Prognostic Factor in a European Cohort of Patients with Upper Tract Urothelial Carcinoma.

Dalpiaz O, Krieger D, Ehrlich GC, Pohlmann K, Stojakovic T, Pummer K, Zigeuner R, Pichler M, Hutterer GC.

Urol Int. 2017;98(3):320-327. doi: 10.1159/000452109. Epub 2016 Oct 13.

PMID:
27732981
12.

Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.

Ulz P, Belic J, Graf R, Auer M, Lafer I, Fischereder K, Webersinke G, Pummer K, Augustin H, Pichler M, Hoefler G, Bauernhofer T, Geigl JB, Heitzer E, Speicher MR.

Nat Commun. 2016 Jun 22;7:12008. doi: 10.1038/ncomms12008.

13.

Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.

Seles M, Hutterer GC, Kiesslich T, Pummer K, Berindan-Neagoe I, Perakis S, Schwarzenbacher D, Stotz M, Gerger A, Pichler M.

Int J Mol Sci. 2016 Apr 15;17(4):573. doi: 10.3390/ijms17040573. Review.

14.

Adjustable Continence Balloons in Men: Adjustments Do Not Translate Into Long-term Continence.

Venturino L, Dalpiaz O, Pummer K, Primus G.

Urology. 2015 Jun;85(6):1448-52. doi: 10.1016/j.urology.2015.01.045.

PMID:
26099887
15.

Preoperative Leucocytosis, Thrombocytosis and Anemia as Potential Prognostic Factors in Non-metastatic Renal Cell Carcinoma.

Hutterer GC, Krieger D, Mrsic E, Pohlmann K, Bezan A, Stojakovic T, Pummer K, Zigeuner R, Pichler M.

Anticancer Res. 2015 Jun;35(6):3463-9.

PMID:
26026111
16.

Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.

Dalpiaz O, Pichler M, Mrsic E, Reitz D, Krieger D, Venturino L, Bezan A, Stojakovic T, Pummer K, Zigeuner R, Hutterer GC.

J Clin Pathol. 2015 Jul;68(7):547-51. doi: 10.1136/jclinpath-2014-202683. Epub 2015 Apr 10.

PMID:
25862811
17.

Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?

Augustin H, Mayerhofer K, Seles M, Pummer K.

Urol Int. 2015;95(2):125-31. doi: 10.1159/000371895. Epub 2015 Mar 17. Review.

18.

Sampling of the anterior apical region results in increased cancer detection and upgrading in transrectal repeat saturation biopsy of the prostate.

Seles M, Gutschi T, Mayrhofer K, Fischereder K, Ehrlich G, Gallé G, Gutschi S, Pachernegg O, Pummer K, Augustin H.

BJU Int. 2016 Apr;117(4):592-7. doi: 10.1111/bju.13108. Epub 2015 May 14.

19.

Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma.

Hutterer GC, Sobolev N, Ehrlich GC, Gutschi T, Stojakovic T, Mannweiler S, Pummer K, Zigeuner R, Pichler M, Dalpiaz O.

J Clin Pathol. 2015 May;68(5):351-5. doi: 10.1136/jclinpath-2014-202658. Epub 2015 Feb 6.

PMID:
25661796
20.

The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma.

Bezan A, Mrsic E, Krieger D, Stojakovic T, Pummer K, Zigeuner R, Hutterer GC, Pichler M.

J Urol. 2015 Jul;194(1):30-5. doi: 10.1016/j.juro.2015.01.083. Epub 2015 Jan 23.

PMID:
25623738

Supplemental Content

Loading ...
Support Center